Bio Key International Inc (BKYI) earnings date, market-implied expected move, and options open interest by expiry

earnings room

2.51−2.14%

Next report

fiscal Q3 2026

Nov 16

before open · estimated date

days out

Intraday

−3.46% since 5 AM

High 2.65 at 4:15 pm ET, low 2.40 at 1:30 pm ET.

Revenue flow

Q2 FY2026 as filed · change vs Q1 FY2026

BKYI lost 30.04% of Q2 FY2026 revenue. Revenue −10.51% on Q1 FY2026, +13.15% on Q2 FY2025.

Revenue$2M−10.51%

Gross profit$2M87.19%−5.38%

Operating income−$529,405−27.57%−235.68%

Pre-tax income−$576,852−181.34%

Net income−$576,852−30.04%−181.34%

What left, as a share of revenue

Cost of revenue$245,951−34.64%

Operating expenses$2M+14.35%

Tax$0—

What else left

Other income−$47,447−0.26%

Standardized lines from BKYI’s own filing for the quarter ended Jun 30 '26. Bars are each line as a share of revenue.

Expected move

No options chain priced for this ticker yet.

Linked exposure

placeholder

No linked names measured for this ticker yet.

Positioning

placeholder

No options positioning captured for this ticker yet.

Earnings history

implied in pale · realized in full ink

Q2 FY26—

−15.65%—

3-quarter memory

Event sensitivity

release-day history · not a forecast

CPIconsumer prices1.4×up 3 of 9±6.7% vs ±4.9% · 9
FOMCrate decision1.0×up 8 of 24±4.9% vs ±4.9% · 24
CPROFcorporate profits0.9×up 2 of 11±4.3% vs ±4.9% · 11
NFPjobs report0.8×up 1 of 9±4.1% vs ±4.9% · 9
PPIproducer prices0.8×up 7 of 9±4.0% vs ±4.9% · 9
GDPgross domestic product0.8×up 6 of 18±4.0% vs ±4.9% · 18
PCEpersonal income & outlays0.6×up 10 of 18±3.1% vs ±4.9% · 18

Past release days against BKYI’s ordinary ±4.9% day, from our own stored closes. History, not a forecast; kinds with fewer than six releases are omitted.

Track BKYI

Watchlist prices, news filtered to it, and its next report on your desk.

Market-implied ranges describe what current option prices imply, never a forecast. Prices via Intrinio.